Literature DB >> 503189

Interferon enhances 2-5A synthetase in embryonal carcinoma cells.

J N Wood, A G Hovanessian.   

Abstract

Mouse teratocarcinomas provide a useful model of mammalian differentiation, because the malignant embryonal carcinoma (EC) stem cells of such tumours may produce various differential cell types in vivo or in vitro. Many EC cell lines have now been established and classified on the basis of their ability to differentiate in vivo into cell types characteristically derived from any of the three germ layers. There is convincing evidence that EC cells can neither produce interferon, nor respond to it by becoming resistant to virus, whereas differentiated cells derived from EC lines behave normally in both respects. We investigated the lack of responsiveness of EC cells towards interferon by measuring the levels of two double-stranded RNA-dependent enzyme activities recently shown to be enhanced by interferon. We report here that on treatment with interferon, EC cells show increased 2-5A synthetase levels comparable to those found in differentiated cells, while there is little or no effect on kinase activity in EC cells, in contrast to their differentiated counterparts.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 503189     DOI: 10.1038/282074a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

1.  Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

Authors:  A De Benedetti; B A Pytel; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 2.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Establishment of the interferon-mediated antiviral state: role of fatty acid cyclooxygenase.

Authors:  R Pottathil; K A Chandrabose; P Cuatrecasas; D J Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line.

Authors:  M Verhaegen; M Divizia; P Vandenbussche; T Kuwata; J Content
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 5.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

6.  Differentiation-dependent activation of interferon-stimulated gene factors and transcription factor NF-kappa B in mouse embryonal carcinoma cells.

Authors:  D V Kalvakolanu; G C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Differential antiviral effects of interferon in three murine cell lines.

Authors:  G C Sen; R E Herz
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

8.  Interferon action in human fibroblasts: induction of 2', 5'-oligoadenylate synthetase in the absence of detectable protein kinase activity.

Authors:  S L Holmes; S L Gupta
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

Review 9.  Tumor viruses and early mouse embryos.

Authors:  F Kelly; H Condamine
Journal:  Biochim Biophys Acta       Date:  1982-04-29

10.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.